AGL Antibody (Center) Blocking Peptide
€293.00
In stock
SKU
AC-BP2402a
Background:
AGL is a glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in the AGL gene are associated with glycogen storage disease although a wide range of enzymatic and clinicalvariability occurs which may be due to tissue-specific alternative splicing.
Other Names: Glycogen debranching enzyme, Glycogen debrancher, 4-alpha-glucanotransferase, Oligo-1,4-1,4-glucantransferase, Amylo-alpha-1,6-glucosidase, Amylo-1,6-glucosidase, Dextrin 6-alpha-D-glucosidase, AGL, GDE
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2402a was selected from the Center region of human AGL . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: P35573
Gene ID: 178
Gene Name: AGL
Format: The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.
Bio References:
Horinishi, A., et al., J. Hum. Genet. 47(2):55-59 (2002).Bao, Y., et al., Genomics 38(2):155-165 (1996).Yang, B.Z., et al., J. Biol. Chem. 267(13):9294-9299 (1992).Yang-Feng, T.L., et al., Genomics 13(4):931-934 (1992).Bao, Y., et al., Gene 197 (1-2), 389-398 (1997).
AGL is a glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in the AGL gene are associated with glycogen storage disease although a wide range of enzymatic and clinicalvariability occurs which may be due to tissue-specific alternative splicing.
Other Names: Glycogen debranching enzyme, Glycogen debrancher, 4-alpha-glucanotransferase, Oligo-1,4-1,4-glucantransferase, Amylo-alpha-1,6-glucosidase, Amylo-1,6-glucosidase, Dextrin 6-alpha-D-glucosidase, AGL, GDE
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2402a was selected from the Center region of human AGL . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: P35573
Gene ID: 178
Gene Name: AGL
Format: The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.
Bio References:
Horinishi, A., et al., J. Hum. Genet. 47(2):55-59 (2002).Bao, Y., et al., Genomics 38(2):155-165 (1996).Yang, B.Z., et al., J. Biol. Chem. 267(13):9294-9299 (1992).Yang-Feng, T.L., et al., Genomics 13(4):931-934 (1992).Bao, Y., et al., Gene 197 (1-2), 389-398 (1997).
| Is Featured? | No |
|---|
Write Your Own Review